Covered recipient · General Payments record
JORDANA S SCHNEIDER
Allopathic & Osteopathic Physicians Psychiatry & Neurology Vascular Neurology
General Payments · PY2023–2024
$811.11
- Reported across 41 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $731.72 | 37 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $367.17 | 20 |
| EISAI INC. | $115.86 | 6 |
| SK Life Science, Inc. | $94.56 | 5 |
| Grifols USA, LLC | $60.20 | 2 |
| Microtransponder, Inc. | $29.14 | 1 |
| Acerta Pharma LLC | $25.39 | 1 |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $21.90 | 1 |
| PFIZER INC. | $17.50 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (37)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $12.14 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106038626 | CMS |
| ABBVIE INC. | $12.62 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106038628 | CMS |
| ABBVIE INC. | $27.70 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106038630 | CMS |
| ABBVIE INC. | $25.03 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106038632 | CMS |
| ABBVIE INC. | $12.28 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106038634 | CMS |
| ABBVIE INC. | $12.28 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106038636 | CMS |
| ABBVIE INC. | $16.96 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106038638 | CMS |
| ABBVIE INC. | $12.55 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106038640 | CMS |
| ABBVIE INC. | $26.00 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106038642 | CMS |
| ABBVIE INC. | $10.67 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106038644 | CMS |
| ABBVIE INC. | $20.13 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106038646 | CMS |
| ABBVIE INC. | $34.33 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106038648 | CMS |
| ABBVIE INC. | $22.06 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106038650 | CMS |
| ABBVIE INC. | $19.67 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106038652 | CMS |
| ABBVIE INC. | $16.91 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106038654 | CMS |
| ABBVIE INC. | $16.78 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106038656 | CMS |
| ABBVIE INC. | $18.72 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106038658 | CMS |
| ABBVIE INC. | $11.78 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106038660 | CMS |
| ABBVIE INC. | $11.78 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106038662 | CMS |
| ABBVIE INC. | $26.78 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106038664 | CMS |
| AstraZeneca Pharmaceuticals LP | $25.39 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104419399 | CMS |
| Eisai Inc. | $13.74 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110754908 | CMS |
| Eisai Inc. | $20.99 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110754904 | CMS |
| Eisai Inc. | $19.11 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110754898 | CMS |
| Eisai Inc. | $17.35 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110754906 | CMS |
| Eisai Inc. | $24.14 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110754900 | CMS |
| Eisai Inc. | $20.53 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110754902 | CMS |
| Grifols USA, LLC | $32.12 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124717532 | CMS |
| Grifols USA, LLC | $28.08 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124717534 | CMS |
| Microtransponder, Inc. | $29.14 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082717620 | CMS |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $21.90 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144512751 | CMS |
| PFIZER INC. | $17.50 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130990246 | CMS |
| SK Life Science, Inc. | $19.00 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154143862 | CMS |
| SK Life Science, Inc. | $21.00 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154143868 | CMS |
| SK Life Science, Inc. | $13.84 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154143902 | CMS |
| SK Life Science, Inc. | $19.03 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154143906 | CMS |
| SK Life Science, Inc. | $21.69 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154143942 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.